Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway

Small‐cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers, and is characterized as extremely aggressive, often displaying rapid tumor growth and multiple organ metastases. In addition, the clinical outcome of SCLC patients is poor due to early relapse and acquired resistance t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Taniguchi, Hirokazu, Yamada, Tadaaki, Takeuchi, Shinji, Arai, Sachiko, Fukuda, Koji, Sakamoto, Shuichi, Kawada, Manabu, Yamaguchi, Hiroyuki, Mukae, Hiroshi, Yano, Seiji
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497807/
https://ncbi.nlm.nih.gov/pubmed/28474864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13268
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados